KVP Capital Advisors »

Travere Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 91k 38.21

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
State Street Corporation
Perceptive Advisors
Adage Capital Partners GP
FMR
Renaissance Technologies
Rock Springs Capital Management
Geode Capital Management
Goldman Sachs Group
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft
Emerald Advisers

View all funds holding Travere Therapeutics